ECG Equipment Market to Mark a Highest CAGR of 5.9% Through 2022| Top Industry Leaders Schiller AG, Nihon Kohden

The global ECG equipment market is expected to reach USD 6.3 billion by 2022, according to a new report by Grand View Research Inc. The rising incidences of cardiovascular disorders and government initiatives to make people aware about health check-ups are expected to boost market growth. In addition, the change in the medical preference from acute intervention to preventive care is expected to increase the demand for more accurate and cost-effective methods for heart monitoring.

According to the WHO, in 2012, around 17.5 million people died due to cardiovascular diseases. This is due to the late diagnosis and absence of early symptoms as the patient fails to keep record of his vital signs.

Owing to the increasing incidences, government is undertaking various awareness programs. According to the American Heart Association (AHA), 56% women identified heart disease as a leading cause of death in 2012 as compared to 30% in 1997.

Access Research Report of ECG Equipment Market@ www.grandviewresearch.com/industry-analysis/ecg-equipment-market

Further key findings from the report suggest:

• ECG monitoring equipment has high future growth potential owing to changing trend towards preventive care and new product innovation with data integration. In February 2014, Medtronic launched its FDA approved Reveal LINQ. The upgraded version of Reveal XT offers patient heart monitoring for three years with 20% more data memory than its previous version.
• ECG stress testing systems is one of the dominating segments of the market. The growing need for flexible stress systems and comprehensive data management is driving the market for this segment. Quinton 9500 series from Cardiac Science portable system allows physicians to optimize the examination space and enables more data integrations.
• Holter monitoring systems is another segment, which is expected to gain significant market share over the forecast period due to the fact that the system assists in identifying arrhythmias that takes place during certain activities such as exercise, stress, bowel movements, sleep, eating, and stress
• 2M Engineering Ltd. launched the VitaMove 2S ExG movement and ECG-recorder, which is equipped with 3-lead ECG holter, that combines daily activities with heart rate events/trends, ECG, and derivatives such as Heart Rate Variability (HRV)
• North America dominated the market in 2014 and is expected to grow at a CAGR of 5.8% over the forecast period. With major industry players situated in North America, the innovations and upgrading rates are higher as compared to other regions. In August 2015, InfoBionic along with Safeguard Scientists raised USD 8 million to commercialize Mome Kardia. Mome Kardia is a remote patient monitoring system based on the cloud technology that could be worn around the neck.
• Asia Pacific is expected to witness substantial growth during the forecast period owing to the rising incidence rate of heart diseases and growing manufacturing outsourcing in the region
• According to the Government of India, the prevalence of heart failure in the nation due to hypertension, obesity, coronary heart disease, obesity, rheumatic heart disease, diabetes ranges from 1.3 to 4.6 million and an annual incidence rate of 491,600 to 1.8 million
• As per a report published by the Associated Chambers of Commerce and Industry of India (ASSOCHAM), people have adopted unhealthy lifestyles along with increasing stress levels, decreasing physical activity, tobacco smoking, and increasing consumption of saturated fats
• Industry players are constantly fueling the market with newer technologies or upgrading existing technology. In May 2015, CardioComm Solutions, Inc. launched HeartCheck PEN. This Bluetooth wireless connectivity pen could be connected for data acquisition with Android and Apple smartphones.
• Apart from technology innovations, many industry players are expanding their global presence by signing distribution agreements with domestic distributors. In October 2015, iNeedMD Holdings, Inc. signed a distribution agreement with Clifton Africa Ltd. This one-year distribution agreement is worth USD 1.5 million.
• Key players of the ECG equipment market include Medtronic, GE Healthcare, Philips Healthcare, Schiller AG, Nihon Kohden, CardioComm Solutions, Inc., and Johnson & Johnson.

Grand View Research has segmented the global ECG equipments market on the basis of product type and region:

ECG equipment type outlook (Revenue, USD Million, 2012 - 2022)

• ECG Monitoring Equipment
• Holter Monitoring Systems
• Event Monitoring Systems
• ECG Stress Testing Systems

ECG equipment regional outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
• RoW
  • Australia
  • Brazil

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Banking Outsourcing Market Expected To Propel Industry Growth By 2022

The global cell banking outsourcing market is expected to reach USD 9.87 billion by 2022, according to a new report by Grand View Research, Inc. Factors attributing towards this anticipated market size include growing demand for gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites.

Additionally, rise in prevalence of oncology associated diseases and other infectious chronic disorders are expected to promote cytological R&D in which cell banking plays a pivotal role thereby driving growth. R&D for commercialization of novel characterization and cryopreservation methods is also expected to considerably enhance lucrative growth opportunities over the forecast period.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/cell-banking-outsourcing-market

Further key findings from the report suggest:

• Master cell banks accounted for over 60% of revenue generated in 2014 owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for stem cell therapy and gene therapy thereby resulting to segment growth.
• Stem cells accounted for the largest share with respect to revenue in cell banking market by cell type. Factors attributive towards large share of this segment include availability of stem cells from different organ origins and there consequent use in different metabolic disorders.
• North America accounted for the largest share of this market for 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for vaccines and biopharmaceuticals is also anticipated to fuel the growth of this region.
• Asia Pacific is expected to witness significant growth in demand over the forecast period owing to increase in number of supportive government initiatives pertaining to investments in biotechnology sector. Additionally, ongoing R&D activities for cancer treatment and fertility preservation facilitate the demand for cell banking services.
• Key participants in the cell banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Lonza, PX’Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., and CordLife.
• Market participants are involved in R&D for characterization of cell banks which include introduction of efficient gene sequencing tests, karyology, and safety tests.

Grand View Research has segmented cell banking outsourcing market on the basis of bank type, cell type, phase of development of cell bank, and region:

Cell Banking Outsourcing Outlook, by Bank Type (Revenue, USD Million, 2012 - 2022 )

• Master Cell Banking
• Working Cell Banking
• Viral Cell Banking

Cell Banking Outsourcing Outlook, by Cell Type (Revenue, USD Million, 2012 - 2022 )

• Stem Cell Banking
  • Cord Stem Cell Banking
  • Embryonic Stem Cell Banking
  • Adult Stem Cell Banking
  • Dental Stem Cell Banking
  • IPS Stem Cell Banking
• Non-stem Cell Banking

Cell Banking Outsourcing Phase Outlook (Revenue, USD Million, 2012 - 2022 )

• Cell Bank Storage
  • Master Cell Bank Storage
  • Working Cell Bank Storage
  • Cell Storage Stability Testing
• Bank Characterization and Testing
  • Safety Testing
    • Viral Cell Bank Safety Testing
    • Microbial Cell Bank Safety Testing
    • Gene Expression Testing
    • Karyology Testing
    • Gene Sequencing Testing
  • Cell Bank Preparation
    • Master Cell Bank Preparation
    • Working Cell Bank Preparation

Cell Banking Outsourcing Regional Outlook (Revenue, USD Million, 2012 – 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • UK
• Asia Pacific
  • Japan
  • China
  • India
  • Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Blood Pressure Monitoring Device Market Expected to Succeed in CAGR of 10.1% by 2026

The global blood pressure (BP) monitoring devices market size is expected to reach USD 2.47 billion by 2026, according to a new report by Grand View Research, Inc. exhibiting a CAGR of 10.1% during the forecast period. The growing global geriatric population base is expected to widen the consumer base by triggering incidence rates of hypertension, which is expected to drive the demand for blood pressure monitoring devices. Increasing incidence of hypertension has led to rising demand for cost-effective, rapid and accurate diagnostic solutions. Blood pressure monitors are one of the vital sign monitors of life. The cost-effective and accurate results offer by these indicators is the factor responsible for the market growth.

In addition, new product launches coupled with rising adoption of technologically advanced products due to high penetration of health insurance is considered as another factor fueling the demand for BP monitoring devices. The increasing popularity of mHealth platform in the healthcare sector is additionally, propelling the market growth. Rising patient awareness levels about advantages associated with portable monitoring devices are expected to positively reinforce market growth.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-pressure-monitoring-devices-market

Further Key Findings From the Report Suggest:

• Sphygmomanometer/ aneroid BP monitors dominated the overall market in 2018 in terms of revenue share, owing to the increasing prevalence of high blood pressure worldwide.
• Ambulatory blood pressure monitoring device market is driven by factors such as increasing adoption by clinicians and awareness about it.
• Digital BP monitors segment is expected to witness lucrative growth in the coming years owing to advantages associated with these devices such as ease of use, immediate results, and low cost. In addition, continuous improvement in these devices is expected to present this market with further growth opportunities.
• Home healthcare segment is expected to witness lucrative growth owing to the government initiatives to promote home healthcare.
• In 2018, North America was the key regional market in terms of revenue share. Key factors attributing to its large share include the presence of advanced healthcare infrastructure and increasing prevalence of lifestyle-associated diseases with a high risk of hypertension.
• Higher awareness levels, increasing demand for early diagnostics & prevention and increasing stress levels leading towards high blood pressure are the factors responsible for the market growth.
• Asia Pacific blood pressure monitoring device market is expected to demonstrate rapid growth during the forecast period with CAGR of 12.2% key factors attributing to its rapid growth include favorable government initiatives such as the government of India's campaign "Make In India" which is intended to attract FDI and international players to invest in Indian market. In addition, rapidly improving healthcare facilities are anticipated to market growth.
• The key players operating in the market include Omron Healthcare, GE Healthcare, A&D Medical Inc., Welch Allyn Inc., SunTech Medical, Inc., Withings, Briggs Healthcare, Microlife AG, Kaz Inc., Philips Healthcare, American Diagnostics Corporation, Rossmax International Ltd., Spacelabs Healthcare Inc., and GF Health Products Inc.

Grand View Research has segmented the global blood pressure monitoring device market on the basis of product, end-use, and region:

Blood Pressure Monitoring Device Product Outlook (Revenue, USD Million; 2014 - 2026)

• Sphygmomanometer/Aneroid BP Monitor
• Automated/Digital Blood Pressure Monitor
  • Arm
  • Wrist
  • Finger
• Ambulatory Blood Pressure Monitor
• Transducers
  • Disposable
  • Reusable
• Instruments and Accessories
  • Blood pressure cuffs
    • Disposable
    • Reusable
  • Others

Blood Pressure Monitoring Devices End-Use Outlook (Revenue, USD Million; 2014 - 2026)

• Hospitals
• Ambulatory Surgical Centers & Clinics
• Home Healthcare

Blood Pressure Monitoring Devices Regional Outlook (Revenue, USD Million; 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Urinary Catheters Market to Partake Significant Development During 2018 to 2024

The global urinary catheters market is expected to reach USD 5.51 billion by 2024, according to a new report by Grand View Research, Inc. The key contributors for the expansion of the market include the rising incidence of urinary disorders, growing elderly population, and technological advancements pertaining to the relevant devices.

These catheters have application in patients suffering from urinary retention, urinary incontinence, benign prostatic hyperplasia, and other disorders. Patients suffering from multiple sclerosis, spina bifida, cerebral palsy, spinal cord injuries, prostate enlargement, and cancer also require need them The WHO states that bladder problems affect more than 200 million people globally. Benign Prostate Hyperplasia (BPH) is most common in the ageing population, especially men, and urinary retention is a very common complication in BPH. Transurethral resection of the prostate is a common surgery for BPH and the Urology Care Foundation estimates that around 150,000 men in the U.S. undergo this surgery each year.

The technological development pertaining to these instruments are expected to drive the demand further. The catheters become infected after a couple of weeks and can cause infection of the tract. The development of new antimicrobial catheters with introduced antimicrobial molecules within the tube has advantage over the traditional ones.

Furthermore, the reimbursement policies for these products can also be attributed to the growing demand. The Medicaid program reimburses a patient with 120 intermittent catheters per month and the Medicare Program reimburses around 200 catheters per month.

Access Research Report of Urinary Catheters Market@ www.grandviewresearch.com/industry-analysis/urinary-catheters-market

Further Key Findings From the Study Suggest:

• In 2015, intermittent catheters was the dominant segment due to less chances of infections associated with their usage and thus being more preferred over the other two types
• In 2015, urinary incontinence was the largest application segment due to the rising prevalence of the disease with aging population.
• North America dominated the market in 2015. The U.S. is the largest market in North America owing to the high prevalence of urology disorders, rising geriatric population, and reimbursement policies.
• Asia Pacific is expected to be the fastest growing during the forecast period owing to the improving infrastructure in emerging economies and increasing interest of large players in this region
• The market dynamics indicate the presence of strong competition amongst the key players like Coloplast; Boston Scientific Corporation; Hollister, Inc.; B Braun Melsungen AG; Teleflex Inc.; Medtronic and many others.

Grand View Research has segmented the urinary catheters market by product, application, and region:

Urinary Catheters Product Type Outlook (Market revenue in USD Million, 2013 - 2024)

• Intermittent catheters
• Foley/ Indwelling catheters
• External catheters

Urinary Catheters Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Benign prostate hyperplasia and prostate gland surgeries
• Urinary incontinence
• Spinal cord injury
• Others

Urinary Catheters Regional Outlook (Market revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Coagulation Analyzer Market to Grow at CAGR of 10.2% through 2024

The global coagulation analyzers/reagents market is expected to reach USD 7.9 billion by 2024, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

• Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
• Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
• Automatic reflex testing, repeat testing, and redilution

Access Research Report of Coagulation Analyzer Market@ www.grandviewresearch.com/industry-analysis/coagulation-analyzers-market

Further key findings from the study suggest:

• Clinical laboratory analyzers held over 70.0% of the market share in 2015 and are predicted to sustain its dominance over the forecast period.
• Advantages such as use of whole blood as sample, no pre-analytical delay and requirement of lesser reagents, further boost growth of Point of Care analyzers.
• Reagents held the highest market share in 2015. This dominance may be attributed to increasing usage of hemostasis analyzers coupled with easy availability of reagents.
• Optical technology based hemostasis analyzers held the largest share in 2015 and is expected to grow at a CAGR of over 6.0% over the forecast period.
• The market is majorly dominated by the prothrombin test. The APTT test is estimated to account for the second largest share in the market in 2015.
• Hospitals are expected to witness lucrative growth over the forecast period. This can be attributed to high number of hospitals in developing economies.
• For instance, Mexico has over 4,500 hospitals and out of these 67.0% hospitals are private and remaining 33.0% hospitals are public hospitals.

Grand View Research has segmented the global Coagulation Analyzers & Reagents market on the basis of product, technology, test type, end-use and region.

Product Outlook (Revenue, USD Million, 2013 - 2024)

• Analyzers
  • Clinical Laboratory Analyzers
  • Point of Care Analyzers   
• Consumables
  • Reagents
  • Stains

Technology Outlook (Revenue, USD Million, 2013 - 2024)

• Mechanical
• Electrochemical
• Optical
  • Photo optical/Chromogenic/Immuno
  • Others/Nephelometric
• Others

Test Type Outlook (Revenue, USD Million, 2013 - 2024)

• APTT
• D-Dimer
• Fibrinogen
• Prothrombin
• Others

End-Use Outlook (Revenue, USD Million, 2013 - 2024)

• Hospitals
• Research Institutes
• Diagnostic Centers
• Others

Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Infection Control Market Expected to Witness a Sustainable Growth over 2025|Key participants STERUS Corporation, Cantel Medical Corporation

The global infection control market is expected to reach USD 258.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is driven by rising concerns with respect to a significant upsurge in hospital acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall infection control market.

The healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern. In addition, increasing number intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years.

For instance, College of Nurses of Ontario released guidelines concerning standard practices, that is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in wide array of healthcare settings such as ambulatory care, home care, hospitals, and others. As a consequence of the aforementioned factors, it is presumed that there will be significant improvement in the overall penetration rate of infection prevention and control products, which is also anticipated to fuel the market demand as well as the revenue to unprecedented heights.

Access Research Report of Infection Control Market@ www.grandviewresearch.com/industry-analysis/infection-control-market

Further key findings from the report suggest:

• In the type segment, services are predicted to observe exponential growth as a consequence of increasing presence of third-party reprocessors and outsourcing of sterilization as a result of associated cost efficiency
• In the end-use segment, hospitals accounted for substantial share in 2016, as a consequence of high clinical urgency to curb the growing incidence of hospital acquired infections
• North America captured a dominant share of the overall infection control market owing to extensive infection prevention activities being implemented in hospitals, medical device and pharmaceutical companies
• The market in Asia Pacific is projected to witness exponential growth during the forecast period as a result of increasing awareness pertaining to spread of infections within healthcare settings and measures for prevention
• The competitive environment is marked by companies adopting sustainability strategies such as geographical expansion and mergers & acquisitions resulting in significant growth in their market share
• For instance, in July 2016, the Getinge Group acquired 1stCall Mobility Ltd, a company specializing in supplying rental equipment. This acquisition was carried out as a part of the company’s expansion strategy

Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

Infection Control Type Outlook (Revenue, USD Billion, 2014 - 2025)

• Equipment
• Services
• Consumables

Infection Control End-use Outlook (Revenue, USD Billion, 2014 - 2025)

• Hospitals
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Infection Control Regional Outlook (Revenue, USD Billion, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Osteoporosis Drugs Market Revenue Sales to Reach USD 16.3 Billion by 2025

The global osteoporosis drugs market is expected to reach USD 16.3 billion by 2025, according to a new study by Grand View Research, Inc. An upsurge rise in the unhealthy lifestyle adoption has resulted in aggravation and increase in the prevalence of osteoporosis which is presumed to propel the osteoporosis drugs market during the forecast period.

In addition, growing number of patent expiries is fueling the high clinical urgency to use generic versions of the established drugs, which is presumed to fuel generic osteoporosis drugs market during the forecast period. The aforementioned factors cumulatively are slated to present the with high potential growth opportunities over the coming years.

Furthermore, rising number of initiatives to increase the awareness levels pertaining to osteoporosis care amongst the patients as well as the physicians is expected to widen the osteoporosis market growth potential during the forecast period. For instance, National Osteoporosis Foundation (NOF), a healthcare organization responsible for National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs that focuses on elevating awareness levels as well as provides training to healthcare professionals

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/osteoporosis-drug-market

Further key findings from the study suggest:

• Branded drugs held the dominant share of the product segment in 2015. The dominant share can be attributed to extensive utilization of bisphosphates, rank ligand inhibitors for the treatment of osteoporosis, possessing high efficacy
• Generics are expected to witness at a lucrative CAGR owing to consistent patent expiries over the coming years as well as high clinical urgency for inexpensive medication in the emerging economies
• In 2015, North America accounted for the largest share in the global osteoporosis drugs market owing to the presence of established companies extensively involved in the commercialization of branded therapeutics
• Asia Pacific is anticipated to grow at an exponential CAGR as a consequence of favorable government initiatives promoting information pertaining to osteoporosis care
• The key participants are employing sustainability strategies promoting the adoption of osteoporosis therapeutics to gain competitive advantage. For instance, Actavis Inc. announced to acquire Warner Chilcott PLC in order to widen their product portfolio

Grand View Research has segmented the osteoporosis drugs market on the basis of product and region:

Global Osteoporosis Product Outlook (Revenue, USD Million, 2014 – 2025)

• Branded
  • Bisphosphonates
  • Parathyroid Hormone Therapy
  • Calcitonin
  • Selective Estrogen Inhibitors Modulator(SERM)
  • Rank Ligand Inhibitors
  • Others
• Generics

Osteoporosis Drugs Regional Outlook (Revenue, USD Billion, 2014 – 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

STD Diagnostics Market Significant Profits Estimated to be Generated by 2022

Global STD diagnostics market is expected to reach USD 200.9 billion by 2022 according to a new study by Grand View Research Inc. The rising geriatric population base, increasing global incidence of various STIs, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the STD diagnostics market growth over the forecast period. 

Increasing number of people having multiple partners and low levels of infection awareness levels are the major drivers fueling industrial growth. Increasing demand for rapid and accurate diagnostic tests and presence of favorable government initiatives for STD testing in developing countries such as Brazil, India, and China are further estimated to boost market growth. 

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/diagnostic-testing-of-stds-market

Further key findings from the study suggest:

• Chlamydia testing accounted for over 34% of the market in 2014. Chlamydia testing for sexually active women aged below 25 years is strictly recommended by the U.S Preventive Services Task Force (PSTF). Syphilis testing is estimated to witness lucrative growth over the forecast period. It is anticipated to grow at a CAGR of 10% owing to increasing prevalence of syphilis infection globally.
• On the basis of test location, laboratory testing held the largest market share of over 63% in 2014 owing to the availability of cost effective diagnostic tests used for multiple STIs at a single location such as public health labs. Point of care on the other hand is anticipated to be the fastest growing segment over the forecast period owing to the owing to the introduction of CLIA waived tests
• Laboratory testing devices dominated the market in 2014 with revenue generation of over 67.0 billion. Immunochromatographic assays were most preferred devices for STD diagnosis in laboratory with revenue share of over 26%. Increasing technological advancements are estimated to enhance usage rates of thermal cyclers over the forecast period.
• Portable/bench top or rapid diagnostic kits are estimated to gain demand over the forecast period owing to features such as user-friendliness, increasing awareness pertaining to self testing, and fast results.
• North America held the largest share of the STD diagnostics market with revenue generation of over 32 billion in 2014. Introduction of technologically advanced diagnostics techniques such as immunochromatographic device by Chembio Diagnostics Systems Inc. is the major factor attributing for its largest market share.
• Asia Pacific region is estimated to witness significant growth over the forecast period owing to the presence of high amount of target population, rising awareness levels for STIs, and increasing government initiatives and rise in disposable income expenditure levels. Asia Pacific is expected to show double digit CAGR growth over the forecast period.
• Major companies of the STD diagnostics industry include Roche Holdings AG, Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Danaher Corporation, Affymetrix, BioMerieux, Cepheid Inc., Alere Inc., DiaSorin, and Orasure
• Licensing and partnership deal making activities in the molecular diagnostics sector are growing significantly in terms of value. New entrants such as life science research groups, financial investors, clinical laboratories, and medical technology players drive up the values. 

Grand View Research has segmented the global STD diagnostics market on the basis of product and region:

Global STD Diagnostics Type Outlook (Revenue, USD Billion, 2012 - 2022)

• Chlamydia testing
• Syphilis testing
• Gonorrhea testing
• Herpes Simplex Virus testing
• Human Papilloma Virus testing
• Human Immunodeficiency Virus testing
• Chancroid testing
• Others

Global STD Diagnostics Location of Testing Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Testing
  • Commercial/Private Labs
  • Public Health Labs
• Point of Care (PoC) testing

Global STD Diagnostics Testing Device Outlook (Revenue, USD Billion, 2012 - 2022)

• Laboratory Devices
  • Thermal Cyclers - PCR
  • Lateral Flow Readers – Immuno chromatographic assays
  • Flow Cytometers
  • Differential Light Scattering machines
  • Absorbance micro plate reader - Enzyme Linked Immunosorbent Assay (ELISA)
  • Others
• Point of Care (PoC) Devices
  • Phone chips (micro fluidics + ICT)
  • Portable/bench top/rapid diagnostic kits

STD Diagnostics Regional Outlook (Revenue, USD Billion, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Sweden
  • Germany
• Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Varicose Vein Treatment Market Set to Witness an Uptick by 2024|Top Industry Leaders Medtronic plc, Dornier MedTech GmbH

The Report Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Stripping, And Segment Forecasts To 2024

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

Access Research Report of Varicose Vein Treatment Market @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest: 

• In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
• The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
• In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
• In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
• As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.
• The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
• Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.
• AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.
• In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.
• In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease. 

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions: 

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)

• Sclerotherapy
• Endovenous Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Compressors Market Predicted to Cross USD 315.88 Million by 2020

Global Dental Compressors Market is expected to reach USD 315.88 Million by 2020, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of dental disorders is expected to drive market growth during the forecast period. Introduction of new products based on oil free technology such as AirStar 12 and AirStar 40 which are maintenance free and provide ultra-dry and clean air are also expected to serve the dental compressors market as drivers. Furthermore, commercialization of membrane based compressors is expected to boost usage rates. Key advantages associated with these compressors include low installation and operating costs, no moving parts and their ability to function in hazardous atmospheres. Moreover, membrane based dryers not only supply hygienic, dry and oil free air but also minimize infection risks and increase treatment efficiency by reducing maintenance levels.

Desiccant based dental compressors were the leading product segment in 2013 owing to its characteristic of not reacting chemically with moisture. In most of the European countries, desiccant compressors are more reliable as the weather in the region can get as high as 30 degree Celsius or as low as 0 degree Celsius. The fact that these compressors exhibit optimum performance at these temperature ranges is expected to drive market growth. Desiccant based compressors are expected to grow at a CAGR over 3.0% during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/dental-compressors-market

Further key findings from the study suggest:

• The oil free compressors market is expected to grow at a CAGR of over 6.0% from 2014 to 2020. Key factors attributing to its fast growth includes their compact size and design enabling them to run smoothly with limited vibration and their ability to provide moisture oil and bacteria free dental air with very low maintenance cost.
• Dental compressors in handpieces accounted for over half of the market owing to rising prevalence of dental disorders, growing number of trained dental professional, rising patient awareness levels and increasing healthcare expenditure levels are few factors attributing to the growth of the dental care industry and the consequent rise in demand for dental compressors in handpieces.
• North America dominated the overall market in terms of market share in 2013 majorly on account of the presence of favorable reimbursement policies, economic development and increasing prevalence of dental disorders.
• The Asia Pacific dental compressors market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population base, rising patient awareness levels and growing prevalence of target diseases are few factors attributing to its rapid growth.
• Key players operating in dental compressors include Midmark, Dürr Dental, Gnatus, Metasys, Tech West Inc, Kaeser Dental, Air Techniques, Aixin Medical Equipment Co., Ltd, Foshan Core Deep Medical Apparatus Co. Ltd, Best Dent Equipment Co., Limited, Slovadent, Dental EZ Group, Diplomat Dental Solutions and Fedesa.

For the purpose of this study, Grand View Research has segmented the global dental compressors market on the basis of product, technology, application and region:

Global Dental Compressors Product Outlook (Revenue, USD Million, 2012 – 2020)

• Dental lubricated compressors
• Dental oil-free compressors

Global Dental Compressors Technology Outlook (Revenue, USD Million, 2012 – 2020)

• Desiccant based compressors
• Membrane based compressors

Global Dental Compressors Application Outlook (Revenue, USD Million, 2012 – 2020)

• Handpieces
• Scalers
• Chair Valves

Dental compressors Regional Outlook (Revenue, USD Million, 2012 – 2020)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• MEA
  • Israel
  • South Africa
• Latin America
  • Brazil 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Imaging Market Booming Trends and Forecast Assessment for the Period 2019 to 2026

The global surgical imaging market size is projected to reach USD 7.3 billion by 2026 expanding at a CAGR of 5.2%, according to a new report by Grand View Research, Inc. Technological advancements and growing demand for minimally invasive surgeries are the key factors augmenting the market growth. Surgical imaging can be used with different modalities, such as optical mode, ultrasound, radiography, and nuclear medicine. Rising scope of applications of imaging modules in a wide range of surgery procedures is expected to create significant opportunities.

Demand for surgical imaging systems is expected to show a steep growth due to high prevalence of chronic diseases including cancer and lifestyle disorders, and rising geriatric population, and demand for non-invasive and minimally invasive surgical methods. The endoscopy and laparoscopy devices are extensively used in minimally invasive surgeries. Key companies in the global market use different strategies to sustain the competition. For instance, in June 2017, Philips acquired Electrical Geodesics, Inc. to launch a portfolio with integrated neurological imaging, therapy, and mapping guidance.

Access Research Report of Surgical Imaging Market @ https://www.grandviewresearch.com/industry-analysis/surgical-imaging-market

Further key findings from the study suggest:

• The X-ray segment is expected to lead the market on account of increasing prevalence of chronic diseases and demand for surgical imaging procedures for better treatment
• The demand for mobile X-ray devices is expected to grow rapidly owing to rising geriatric population and need for bedside imaging
• Orthopedic and trauma is anticipated to be the largest and fastest-growing application segment over the forecast years
• C-arms is expected to be the fastest-growing device segment in the global surgical imaging market
• North America accounted for the largest share with U.S. capturing the largest share of the regional market in 2017
• Some of the key companies include Siemens Healthcare; Hitachi Ltd.; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic, Inc.; Medtronic, PLC; and Shimadzu Corporation

Grand View Research has segmented the global surgical imaging market on the basis of device, modality, application, and region:

Surgical Imaging Device Outlook (Revenue, USD Million, 2014 - 2026)

• Endoscopy
• Laparoscopy
• Angiography
• C-arms
• Surgical Navigation Systems

Surgical Imaging Modality Outlook (Revenue, USD Million, 2014 - 2026)

• MRI
• X-ray
• Computed Tomography
• Optical
• Nuclear Imaging
• Ultrasound

Surgical Imaging Application Outlook (Revenue, USD Million, 2014 - 2026)

• Neurosurgeries
• Cardiovascular
• Orthopedic and Trauma
• Gynecological
• Ophthalmological
• Thoracic
• Urologic
• Other

Surgical Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Disposables Market Analysis By Leading Players, Types, Growth Factors, Demand, Opportunities

The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure.

In addition, propelling factors of this sector comprise constantly rising hospital visits, surgeries, and the growing need for healthcare assistance owing to the escalating geriatric population prone to developing chronic diseases and injuries. Furthermore, the emergence of this sector is attributed to the increased focus toward the use of single-use disposable products to prevent cross-contamination and infection in healthcare settings.

These products offer a range of advantages to the healthcare institutions such as reducing sterilization and disinfection costs. Thus, most of the healthcare professionals and individual patients are turning toward disposable medical supplies to meet the infection control requirements.

Drug delivery products captured the largest revenue share in 2015. The segment is also expected to foresee the fastest growth rate due to the increasing use of prefilled syringes, needles, and transdermal patches by various hospitals and clinics.

The plastic resin segment accounted for the largest share in 2015 due to their wide availability and application in the healthcare sector. However, nonwoven material is forecasted to grow at the fastest CAGR owing to factors such as their low weight, affordable cost, and easy recycling methods. Nonwoven fabric is the material of choice for a number of applications such as wound care management, incontinence management, and surgeries due to the highly absorbent and liquid repellent nature of this material, among other properties.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-disposables-market

Further Key Findings from the Study Suggest:

• In 2015, the drug delivery product segment captured the largest revenue share. The increasing application of various drug delivery products for sustained-release drug therapies is mainly contributing to the largest share of the segment globally.
• In addition, rising demand for minimally invasive surgeries is spurring the demand for needles and drug delivery devices, which is resulting in the high revenue generation of the segment
• With the introduction of advanced technology and growing demand for accurate diagnostic methods, the diagnostic and laboratory disposables segment is expected to show the second fastest growth during the forecast period
• North America region dominated the overall market by capturing over 35.0% share in 2015. This region is anticipated to remain dominant throughout the forecast period.
• Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, large patient pool, and the presence of a large number of major players in the region
• Growing economies and government-led initiatives are expected to drive the growth of the medical disposables sector in the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 7% during the forecast period.
• Some of the major players in the consolidated market are 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health

Grand View Research has segmented the medical disposables market by product, raw material, end use, and region:

Type Outlook (Market revenue in USD Million, 2014 - 2024)

• Wound Management Products
• Drug Delivery Products
• Diagnostic and Laboratory Disposables
• Dialysis Disposables
• Incontinence Products
• Respiratory Supplies
• Sterilization Supplies
• Nonwoven Disposables
• Others

Raw Material Outlook (Market revenue in USD Million, 2014 - 2024)

• Plastic Resins
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others

End Use Outlook (Market revenue in USD Million, 2014 - 2024)

• Hospitals
• Home Healthcare
• Outpatient/Primary care Facilities
• Others

Regional Outlook (Market Revenue in USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pyrogen Testing Market Poised to Expand at a Robust Pace Over 2025

The global pyrogen testing market is expected to reach a value of USD 1.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels growth of the market during forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases, is another foremost factor supporting the growth of the pyrogen testing market. The prevalence of chronic diseases is very high in developed countries and is growing at high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise leads to occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.  Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

Access Research Report of Pyrogen Testing Market @ https://www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further key findings from the study suggest:

• Consumables was the largest revenue grossing segment of the pyrogen testing market in 2016, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase
• Instruments segment accounted for the remarkable share in the market in 2016 and is also expected to showcase significant growth during forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis
• The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2016, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development
• North America is the leading regional market and accounted for the largest revenue share in 2016 primarily due to the existence of large number of healthcare companies including pharmaceuticals and medical devices in this region
• The Asia Pacific region is anticipated to be the fastest growing market during the study period. The growing prevalence rate of chronic diseases in the Asian countries including India and China, is a major factor contributing to the expansion of market in this region.
• Some major players serving this vertical include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA; GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates of Cape Cod, Inc.; and Pyrostar

Grand View Research has segmented the pyrogen testing market on the basis of product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Million; 2014 - 2025)

• Consumables
• Instruments
• Services

Pyrogen Testing Test Type Outlook (Revenue, USD Million; 2014 - 2025)

• LAL test
• Chromogenic test
• Turbidimetric test
• Gel clot test
• In vitro pyrogen test         
• Rabbit test

Pyrogen Testing End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Pharmaceutical and biotechnology companies
• Medical devices companies
• Others

Pyrogen Testing Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hyperbaric Oxygen Therapy Devices Market to Expand At A CAGR Of 6.5% through 2025|Key participants IHC Hytech B.V.

The Report Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market Analysis By Product (Monoplace, Multiplace, Topical HBOT Devices), By Application (Wound Healing, Infection Treatment, Gas Embolism), And Segment Forecasts, 2018 - 2025

The global hyperbaric oxygen therapy devices market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.

Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.

According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.

Access Research Report of Hyperbaric Oxygen Therapy Devices Market @ www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further Key Findings From the Report Suggest:

• The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
• Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
• Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
• Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.

Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:

HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Monoplace HBOT Devices
• Multiplace HBOT Devices
• Topical HBOT Devices

HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

• Wound Healing
• Decompression Sickness
• Infection Treatment
• Gas Embolism
• Others

HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ePharmacy Market Expected To Expand At A CAGR Of 14.8% From 2018 To 2025

The global ePharmacy market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Access Research Report of ePharmacy Market @ https://www.grandviewresearch.com/industry-analysis/epharmacies-market

Further Key Findings From the Report Suggest:

• North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
• The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
• Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure
• Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

Grand View Research has segmented the ePharmacy market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.